A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in ...

In a recent study published in Developmental Cell, researchers at Karolinska Institutet created a comprehensive map of ...

A new publication shines a spotlight on HER3, a long-overlooked member of the ErbB receptor family, revealing its critical ...

High-risk neuroblastoma kills roughly half of affected children because the tumor can switch cell identity and evade therapy.

Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and ...

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Optieum ...

Despite the efforts of the scientific community, cancer is still a leading cause of death worldwide. Immunotherapy, a ground-breaking strategy for cancer ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been published in ...

Across patient tumors, resistant cancer cells consistently converge on a proliferation phenotype driven by ERBB pathway activation, associated with intensified ... resistance by targeting the ...